<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">10860211</PMID>
        <DateCompleted>
            <Year>2000</Year>
            <Month>10</Month>
            <Day>19</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2019</Year>
            <Month>05</Month>
            <Day>03</Day>
        </DateRevised>
        <Article PubModel="Print">
            <Journal>
                <ISSN IssnType="Print">0306-6800</ISSN>
                <JournalIssue CitedMedium="Print">
                    <Volume>26</Volume>
                    <Issue>3</Issue>
                    <PubDate>
                        <Year>2000</Year>
                        <Month>Jun</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Journal of medical ethics</Title>
                <ISOAbbreviation>J Med Ethics</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Justified deception? The single blind placebo in drug research.</ArticleTitle>
            <Pagination>
                <MedlinePgn>188-93</MedlinePgn>
            </Pagination>
            <Abstract>
                <AbstractText>&quot;Run-in&quot; and &quot;washout&quot; periods involving the withholding of medication are widely used in drug research trials in pursuit of both patient safety and scientific reliability. Such no-medication periods can be justified ethically provided that they are apparent to patients, who can thereby properly consent to undergoing them. Less widespread, but still common, is the practice of &quot;single blinding&quot; no-medication periods, concealing them from patients by means of placebo. Whilst all placebos involve a measure of concealment, their use is typically justified in drug research trials (i) by their preserving the uncertainty generated by the random allocation of different treatments within a drug trial; and (ii) by the researchers openly declaring both the randomisation process and the chances of receiving placebo. In the single blind placebo &quot;run-in&quot; or &quot;washout&quot;, neither of these conditions is met. This paper considers three possible defences of the practice of using single blind placebo &quot;run-ins&quot; or &quot;washouts&quot; and finds them all to fail; the practice appears ethically unjustified.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Evans</LastName>
                    <ForeName>M</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Centre for Philosophy and Health Care, School of Health Science, University of Wales Swansea.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>J Med Ethics</MedlineTA>
            <NlmUniqueID>7513619</NlmUniqueID>
            <ISSNLinking>0306-6800</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>E</CitationSubset>
        <CitationSubset>IM</CitationSubset>
        <CommentsCorrectionsList>
            <CommentsCorrections RefType="CommentIn">
                <RefSource>J Med Ethics. 2000 Dec;26(6):477</RefSource>
                <PMID Version="1">11129852</PMID>
            </CommentsCorrections>
        </CommentsCorrectionsList>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D002986" MajorTopicYN="N">Clinical Trials as Topic</DescriptorName>
                <QualifierName UI="Q000331" MajorTopicYN="Y">legislation &amp; jurisprudence</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008192" MajorTopicYN="Y">Deception</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D004992" MajorTopicYN="Y">Ethics, Medical</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D007258" MajorTopicYN="N">Informed Consent</DescriptorName>
                <QualifierName UI="Q000331" MajorTopicYN="N">legislation &amp; jurisprudence</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D009014" MajorTopicYN="N">Morals</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D035842" MajorTopicYN="N">Research Subjects</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D016037" MajorTopicYN="Y">Single-Blind Method</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D036302" MajorTopicYN="N">Therapeutic Human Experimentation</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
        <OtherID Source="KIE">65530</OtherID>
        <KeywordList Owner="KIE">
            <Keyword MajorTopicYN="N">Biomedical and Behavioral Research</Keyword>
        </KeywordList>
        <GeneralNote Owner="KIE">17 fn.</GeneralNote>
        <GeneralNote Owner="KIE">KIE BoB Subject Heading: human experimentation/research design</GeneralNote>
        <GeneralNote Owner="KIE">Full author name: Evans, Martyn</GeneralNote>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2000</Year>
                <Month>6</Month>
                <Day>22</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2000</Year>
                <Month>10</Month>
                <Day>21</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2000</Year>
                <Month>6</Month>
                <Day>22</Day>
                <Hour>0</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">10860211</ArticleId>
            <ArticleId IdType="pmc">PMC1733215</ArticleId>
            <ArticleId IdType="doi">10.1136/jme.26.3.188</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>J Cardiovasc Pharmacol. 1995 Apr;25(4):619-24</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">7596131</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Hypertens. 1995 May;8(5 Pt 1):494-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">7662226</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cardiovasc Drugs Ther. 1995 Jun;9(3):413-20</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8527351</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Cardiovasc Pharmacol. 1993 Jan;21(1):84-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">7678684</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Arch Gen Psychiatry. 1965 Apr;12:36-45</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">14258363</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BMJ. 1997 Apr 19;314(7088):1191-3</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9146400</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>

</PubmedArticleSet>
